Brasilia, Jun 27 (Prensa Latina) The new vaccine against dengue called Qdenga has already arrived in Brazil to be applied through private health network. It´s not yet available in the Unified Health System (SUS).
By Reuters Staff
2 Min Read
FILE PHOTO: A medic fills a syringe with COVAXIN, an Indian government-backed COVID-19 vaccine, before administering it to a health worker during its trials, at the Gujarat Medical Education and Research Society in Ahmedabad, India, November 26, 2020. REUTERS/Amit Dave
SAO PAULO (Reuters) - Brazil’s private sector vaccine clinics will be able to give customers a COVID-19 shot developed by India’s Bharat Biotech once Brazil’s federal health regulator has approved the drug, the head of the Brazilian Association of Vaccine Clinics (ABCVAC) said on Wednesday.
Speaking after a trip to visit Bharat Biotech executives in India, ABCVAC President Geraldo Barbosa said that private sector talks to acquire Bharat’s COVAXIN vaccine would not interfere with the Brazilian government’s efforts to acquire vaccines for the public sector.
Bharat Biotech said that it had signed an agreement with a Brazil-based pharmaceutical seller (File)
Sao Paulo:
Brazil s private sector vaccine clinics will be able to give customers a COVID-19 shot developed by Bharat Biotech once Brazil s federal health regulator has approved the drug, the head of the Brazilian Association of Vaccine Clinics (ABCVAC) said on Wednesday.
Speaking after a trip to visit Bharat Biotech executives in India, ABCVAC President Geraldo Barbosa said that private sector talks to acquire Bharat s COVAXIN vaccine would not interfere with the Brazilian government s efforts to acquire vaccines for the public sector.
Barbosa said that private clinics would only be able to buy the vaccine once health regulator Anvisa has signed off on the drug. He did not say whether a deal with Bharat had been signed, nor did he provide specific numbers on the size of any order.
Brazil scrambles to secure COVID vaccine from India
Sun Online Desk
10th January, 2021 10:13:06
Brazil made a diplomatic push on Monday to guarantee an Indian-made shipment of British drugmaker AstraZeneca’s COVID-19 vaccine, hoping to avoid export restrictions that could delay immunisations during the world’s second-deadliest outbreak.
In parallel, Brazil’s private clinics struck a preliminary deal for an alternative injection made by India’s Bharat Biotech despite a lack of public results from late-stage trials.
The scramble by Brazil’s government and private sector underscored how Latin America’s largest nation, once an example of mass immunisation success in the developing world, has fallen behind peers in the race to inoculate against the coronavirus.